Follow
Sarah Cianferani
Sarah Cianferani
CNRS
Verified email at unistra.fr
Title
Cited by
Cited by
Year
Characterization of therapeutic antibodies and related products
A Beck, E Wagner-Rousset, D Ayoub, A Van Dorsselaer, ...
Analytical chemistry 85 (2), 715-736, 2013
6662013
Poly (ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression
C Boehler, LR Gauthier, O Mortusewicz, DS Biard, JM Saliou, A Bresson, ...
Proceedings of the National Academy of Sciences 108 (7), 2783-2788, 2011
3242011
Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry
A Beck, S Sanglier-Cianférani, A Van Dorsselaer
Analytical chemistry 84 (11), 4637-4646, 2012
3072012
2-D structure of the A region of Xist RNA and its implication for PRC2 association
S Maenner, M Blaud, L Fouillen, A Savoye, V Marchand, A Dubois, ...
PLoS biology 8 (1), e1000276, 2010
2912010
Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma
B Herquel, K Ouararhni, K Khetchoumian, M Ignat, M Teletin, M Mark, ...
Proceedings of the National Academy of Sciences 108 (20), 8212-8217, 2011
2342011
A sulfenic acid enzyme intermediate is involved in the catalytic mechanism of peptide methionine sulfoxide reductase fromEscherichia coli
S Boschi-Muller, S Azza, S Sanglier-Cianferani, F Talfournier, ...
Journal of Biological Chemistry 275 (46), 35908-35913, 2000
2322000
Innovative native MS methodologies for antibody drug conjugate characterization: high resolution native MS and IM-MS for average DAR and DAR distribution assessment
F Debaene, A Boeuf, E Wagner-Rousset, O Colas, D Ayoub, N Corvaia, ...
Analytical chemistry 86 (21), 10674-10683, 2014
1962014
Proline: an efficient and user-friendly software suite for large-scale proteomics
D Bouyssié, AM Hesse, E Mouton-Barbosa, M Rompais, C Macron, ...
Bioinformatics 36 (10), 3148-3155, 2020
1852020
Adding a new separation dimension to MS and LC–MS: what is the utility of ion mobility spectrometry?
V d'Atri, T Causon, O Hernandez‐Alba, A Mutabazi, JL Veuthey, ...
Journal of separation science 41 (1), 20-67, 2018
1792018
Aβ (1-42) tetramer and octamer structures reveal edge conductivity pores as a mechanism for membrane damage
S Ciudad, E Puig, T Botzanowski, M Meigooni, AS Arango, J Do, ...
Nature communications 11 (1), 3014, 2020
1522020
Analytical characterization of biosimilar antibodies and Fc-fusion proteins
A Beck, H Diemer, D Ayoub, F Debaene, E Wagner-Rousset, C Carapito, ...
TrAC Trends in Analytical Chemistry 48, 81-95, 2013
1492013
A novel mechano‐enzymatic cleavage mechanism underlies transthyretin amyloidogenesis
J Marcoux, PP Mangione, R Porcari, MT Degiacomi, G Verona, GW Taylor, ...
EMBO molecular medicine 7 (10), 1337-1349, 2015
1452015
Cutting‐edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies
A Beck, F Debaene, H Diemer, E Wagner‐Rousset, O Colas, ...
Journal of Mass Spectrometry 50 (2), 285-297, 2015
1452015
Characterization of the methionine sulfoxide reductase activities of PILB, a probable virulence factor from Neisseria meningitidis
A Olry, S Boschi-Muller, M Marraud, S Sanglier-Cianferani, ...
Journal of Biological Chemistry 277 (14), 12016-12022, 2002
1442002
Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine‐linked antibody drug conjugate
J Marcoux, T Champion, O Colas, E Wagner‐Rousset, N Corvaïa, ...
Protein Science 24 (8), 1210-1223, 2015
1382015
Physiologically relevant reconstitution of iron-sulfur cluster biosynthesis uncovers persulfide-processing functions of ferredoxin-2 and frataxin
S Gervason, D Larkem, AB Mansour, T Botzanowski, CS Müller, ...
Nature communications 10 (1), 3566, 2019
1322019
Simultaneous Self‐Assembly of a [2] Catenane, a Trefoil Knot, and a Solomon Link From a Simple Pair of Ligands
T Prakasam, M Lusi, M Elhabiri, C Platas‐Iglesias, JC Olsen, Z Asfari, ...
Angewandte Chemie 125 (38), 10140-10144, 2013
1122013
Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates
A Beck, G Terral, F Debaene, E Wagner-Rousset, J Marcoux, ...
Expert review of proteomics 13 (2), 157-183, 2016
1092016
Native MS: An’ESI ‚way to support structure-and fragment-based drug discovery
V Vivat Hannah, C Atmanene, D Zeyer, A Van Dorsselaer, ...
Future medicinal chemistry 2 (1), 35-50, 2010
1052010
An online four-dimensional HIC× SEC-IM× MS methodology for proof-of-concept characterization of antibody drug conjugates
A Ehkirch, V d’Atri, F Rouviere, O Hernandez-Alba, A Goyon, O Colas, ...
Analytical chemistry 90 (3), 1578-1586, 2018
992018
The system can't perform the operation now. Try again later.
Articles 1–20